DI
ABBV icon

Disciplined Investors’s AbbVie ABBV Stock Holding History

Disciplined Investors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$375K Buy
1,492
+50
+3% +$10.8K 0.19% 101
2026
Q1 		$314K Sell
1,442
-18
-1% -$3.99K 0.19% 100
2025
Q4 		$334K Buy
1,460
+26
+2% +$5.92K 0.22% 90
2025
Q3 		$332K Sell
1,434
-96
-6% -$19.5K 0.24% 86
2025
Q2 		$284K Buy
1,530
+5
+0.3% +$929 0.22% 92
2025
Q1 		$319K Buy
1,525
+299
+24% +$58.1K 0.29% 75
2024
Q4 		$217K Buy
+1,226
New +$225K 0.21% 100

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Disciplined Investors's ABBV Position: Q2 2026 in Review

Disciplined Investors increased its AbbVie (ABBV) stake by 3.5% in Q2 2026, buying an estimated $10.8K and bringing the position to 1,492 shares worth $375K. The position accounts for 0.19% of the portfolio, ranked #101.

Disciplined Investors first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Disciplined Investors held 1,492 shares of AbbVie worth $375K as of Q2 2026.
  • Disciplined Investors bought 50 AbbVie shares in Q2 2026, an estimated $10.8K.
  • AbbVie made up 0.19% of Disciplined Investors's portfolio in Q2 2026, its #101 holding.
  • Disciplined Investors first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Disciplined Investors's 13F filing for Q2 2026, filed 11 Aug 2026.